RENAL BLOOD FLOW is highly regulated, with at least three intrinsic renal mechanisms contributing to its fine control: myogenic response, tubuloglomerular feedback (TGF), and connecting tubule glomerular feedback (CTGF) (5, 13, 27) . In the myogenic response, the afferent arteriole (Af-Art) constricts in response to increases in perfusion pressure. Because of its very short activation delay, the myogenic response is particularly well-suited for isolating glomerular capillaries from rapidly changing renal perfusion pressure (21) . Increased glomerular capillary pressure leads to endothelial, mesangial, and podocyte injury, which ultimately results in glomerulosclerosis (2) . Myogenic response is an important component of the overall renal autoregulation (17) . Therefore, the myogenic response plays an important role in preventing excessive glomerular capillary pressure, and consequent glomerular barotrauma.
Salt-sensitive hypertension, defined as an increase in blood pressure (BP) in response to excess sodium intake, is common in hypertensive patients, particularly in the elderly, diabetics, African-Americans, and obese patients (7) . Salt sensitivity is associated with a higher risk of developing glomerulosclerosis and renal failure (19) , possibly due to higher glomerular capillary pressures. In a comparison between salt-resistant and salt-sensitive patients, calculated intraglomerular pressure fell in the former but increased in the latter in response to highNaCl intake (6) .
Although the myogenic response has been studied extensively in normotensive animals, less is known of how the myogenic response is affected in hypertensive models. We recently found that spontaneously hypertensive rats (SHR) have an enhanced myogenic response (25) , a fact that may help explain the remarkably little glomerular injury seen in this hypertensive strain. On the other hand, it has been proposed that in Dahl salt-sensitive (Dahl SS) rats a defect in myogenic autoregulation can lead to glomerular barotrauma, and it explains their susceptibility to hypertensive nephropathy (23) .
In normotensive animals, the myogenic response is mediated by extracellular ATP acting on P2X receptors (14) . And the effect of P2X receptor activation is in turn mediated by 20-HETE (13) . Furthermore, inhibitors of 20-HETE formation and action blunt the effect of and the myogenic response in vitro and renal autoregulation in vivo (18, 36) , suggesting that 20-HETE may be a second messenger of the myogenic response downstream from ATP.
The role of 20-HETE in the impairment of Af-Art myogenic response in Dahl SS rats is unknown, but Dahl SS rats are known to have a decreased 20-HETE production in renal microvessels (32) . Thus, we hypothesize that a decrease in 20-HETE in Dahl SS rats causes an impairment in myogenic response and ATP-induced Af-Art constriction.
METHODS
We used methods similar to those previously described to isolate the Af-Art with glomerulus intact (16, 26) . Young male Dahl SS and age-matched salt-resistant (Dahl SR) and Sprague-Dawley (SD) rats (Harlan Laboratories, Indianapolis, IN) were used (body wt 100 -150 g). Both kidneys were removed under ketamine/xylazine anesthesia and sliced longitudinally along the corticomedullary axis. 
Microdissection and Microperfusion of Af-Arts
The kidney slices were placed in ice-cold minimum essential medium (MEM; GIBCO) containing 5% BSA (Intergen), and a single superficial Af-Art with glomerulus intact was microdissected under a stereomicroscope. With the use of a micropipette, the arteriole was transferred to a temperature-controlled chamber mounted on an inverted microscope (IMT-2; Olympus) with Hoffmann modulation and cannulated with an array of glass pipettes. Af-Arts were perfused from the proximal end in an orthograde direction. Intraluminal pressure was measured by Landis' technique using a fine pipette introduced into the arteriole through the perfusion pipette (20) . Microdissection and cannulation were completed within 90 min at 2-8°C, after which the bath was gradually warmed to 37°C for the rest of the experiment. Once temperature was stable, a 30-min equilibration period was allowed before any measurements were taken. Images of the Af-Art were displayed at magnifications up to ϫ1,980, recorded at 5-s intervals with a video camera, and measured with a computer equipped with Metavue image analysis system (MDS Analytical Technologies, Toronto, Canada). For the purpose of standardizing our measurements, each data point resulted from averaging three individual measurements. One measurement was taken at the site of maximal constriction, one 5 m upstream from it, and one 5 m downstream from it. Maximal constriction usually occurred in the proximal or mid parts of the Af-Art. To examine the myogenic response in Af-Arts, we monitored their luminal diameter for 5 min after raising intraluminal pressure in 20-mmHg increments from 60 to 140 mmHg. Then, pressure was returned to 60 mmHg, and a second curve was constructed with the addition of various pharmacological agents in the bath and lumen of the Af-Art. This is based on our previous experience showing that the myogenic response is stable and reproducible (25) .
Experimental Protocols
Response of the Af-Art to increased intraluminal pressure. Myogenic response experiments were conducted as described above. Here, we compared the myogenic response of Dahl SS and Dahl SR rats.
Effect of 20-HEDE on the myogenic response. Using Dahl SS, Dahl SR, and SD rats, we constructed two consecutive myogenic response curves, the second in the presence of 20-HEDE (a 20-HETE antagonist; 10 Ϫ6 M).
Effect of a subconstrictor concentration of exogenous 20-HETE or norepinephrine on the myogenic response in Dahl SS rats.
We evaluated whether a subconstrictor concentration of exogenous 20-HETE (5 ϫ 10 Ϫ8 M) could restore the myogenic response in Dahl SS. As a control, we repeated this experiment using a subconstrictor concentration of norepinephrine (NE; 5 ϫ 10 Ϫ8 M, which is the highest concentration of NE that did not induce Af-Art constriction in our previous experiments).
Effect of exogenous ATP on Af-Art constriction. We induced Af-Art constriction by using the ectonucleotidase-resistant ATP analog ␣,␤-methylene-ATP (10 Ϫ6 M) in Dahl SS and Dahl SR rats.
Effect of 20-HEDE on ATP-induced Af-Art constriction in Dahl SR
and Dahl SS rats. We induced Af-Art constriction with ␣,␤-methylene-ATP as above, two consecutive times, the second in the presence 20-HEDE.
Statistics
Baseline Af-Art diameters were not significantly different between Dahl SS and Dahl SR. Experiments comparing curves obtained from different groups of animals were analyzed using repeated-measures ANOVA, followed by pairwise comparisons using the pooled variance from the ANOVA. Experiments comparing two curves obtained sequentially in the same preparation (i.e., control and treated) were analyzed using a paired t-test. Data are expressed as means Ϯ SE. When multiple comparisons were performed, Hochberg's adjustment was used to determine significance.
RESULTS

Response of the Af-Art to Increased Intraluminal Pressure
As expected, Dahl SR Af-Arts displayed myogenic response by constricting in response to increasing perfusion pressure. However, Dahl SS Af-Arts remained essentially unchanged; i.e., they were neither distended by increasing intraluminal pressure, nor did they exhibit any measurable constriction (Fig. 1) . Thus, Dahl SS displayed impaired myogenic response compared with Dahl SR.
Effect of 20-HEDE on the Myogenic Response
To test whether 20-HETE contributes to myogenic response, and whether its contribution is different in Dahl SS and Dahl SR, we used the 20-HETE antagonist 20-HEDE. As an additional control, we also studied SD Af-Arts. 20-HEDE blocked the myogenic response in both Dahl SR ( Fig. 2A) and SD rats (Fig. 2B) . In contrast, adding 20-HEDE to Dahl SS Af-Arts had no effect on luminal diameter (Fig. 2C ). These data suggest that a decrease in 20-HETE may explain the impairment seen in myogenic response in Dahl SS.
Effect of a Subconstrictor Concentration of Exogenous 20-HETE or NE on the Myogenic Response in Dahl SS Rats
To confirm that a decrease in 20-HETE participates in the attenuation of myogenic response seen in Dahl SS, we added a subconstrictor concentration of exogenous 20-HETE. As summarized in Fig. 3A, 20 -HETE restored the myogenic response. As a control, we repeated this experiment but adding NE instead of 20-HETE, at the highest concentration that does not cause constriction, based on previous experiments. As shown in Fig. 3B , a subconstrictor concentration of NE did not affect the myogenic response. These data support the hypothesis that the attenuation of myogenic response seen in Dahl SS rats is due to lack of 20-HETE, rather than a nonspecific defect in vascular smooth muscle contraction.
Effect of Exogenous ATP on Af-Art Constriction
Because Af-Art autoregulation has been shown to be mediated by ATP and 20-HETE, with 20-HETE being downstream from ATP (34, 35), we tested whether the response to exogenous ATP was different in Dahl SS and Dahl SR, using the phosphodiesterase-resistant, P2X-selective ATP analog ␣,␤-methylene-ATP. As summarized in Fig. 4 , ␣,␤-methylene-ATP 10 Ϫ6 M decreased Af-Art diameter from 14.6 Ϯ 0.9 to 7.2 Ϯ 0.8 m in Dahl SR (n ϭ 6), but only from 14.5 Ϯ 0.8 to 13.0 Ϯ 0.6 m in Dahl SS (n ϭ 8, P Ͻ 0.001 Dahl SS vs. Dahl SR), suggesting an impairment in ATP-induced constriction in Dahl SS.
Effect of 20-HEDE on ATP-Induced Af-Art Constriction in Dahl SR and Dahl SS Rats
We then studied whether 20-HETE also participated in ATP-induced constriction. We induced Af-Art constriction two consecutive times, the second in the presence of the 20-HETE antagonist 20-HEDE. As summarized in Fig. 5A , ␣,␤-methylene-ATP decreased Af-Art diameter in Dahl SR from 14.6 Ϯ 0.9 to 7.2 Ϯ 0.8 m during the control period, whereas after the addition of 20-HEDE (10 Ϫ6 M), Af-Art diameter decreased only from 13.7 Ϯ 0.9 to 12.1 Ϯ 1.0 m (n ϭ 6, P Ͻ 0.01). As a control, we showed that in the presence of vehicle, ATPinduced constriction was stable and reproducible (first period 16.3 Ϯ 0.6 to 6.8 Ϯ 0.5 m, second period 16.6 Ϯ 0.7 to 6.2 Ϯ Fig. 5D ). Similarly to our findings with the myogenic response, these data suggest that under normal conditions ATP-induced constriction also requires 20-HETE, but in Dahl SS rats there is impairment in ATP-induced constriction due to a lack of 20-HETE.
DISCUSSION
Current knowledge of the mechanisms underlying the myogenic response comes mainly from two separate sets of studies. First, a link between pressure-dependent autoregulation and purinergic receptor activation had been found based on studies performed in the in vitro blood-perfused juxtamedullary nephron technique (14) , and we confirmed this is the case in our isolated afferent arteriole preparation. Second, based on other vascular bed studies, it had been suggested that 20-HETE may be a downstream mediator of ATP in Af-Arts (13), and Zhao et al. showed that 20-HETE mediates the calcium response (34) and constriction (35) of renal microvascular cells to P2X receptor activation. Thus, it is reasonable to propose that increases in transmural pressure cause myogenic constriction of Af-Arts by acting through P2X receptors and 20-HETE. Here, we report that indeed this is the case, as our present studies connect the pathway from transmural pressure, to ATP, to 20-HETE. This is consistent with the recent demonstration by Ge et al. (11) that the myogenic response can be blocked by inhibiting 20-HETE. Our studies are also in keeping with previous reports in which 20-HETE appears to be a common pathway for other stimuli that constrict the Af-Art, including endothelin-1 (12) , and ANG II (1). Our data indicate that 20-HETE participates in the myogenic response and that a decrease in 20-HETE underlies the impairment seen in myogenic response and ATP-induced constriction in Dahl SS rats. Of note, since a single subconstrictor concentration of 20-HETE was able to fully restore the myogenic response in Dahl SS rats, our studies do not prove a mediator function for 20-HETE, but rather suggest a permissive function to enable Af-Art constriction. Furthermore, a permissive role of 20-HETE in Af-Art constriction is more consistent with the literature showing a participation of 20-HETE in a wide variety of constrictor stimuli [pressure in our experiments, ANG II and endothelin-1 in previous studies (1, 12) ]. It is also consistent with Yousif et al. (33) , who considered the possibility that 20-HETE acted as a permissive factor in the constrictor response of the mesenteric arteries to NE, endothelin-1, and ANG II.
Although the P2X receptor is in itself a cation channel, it is also possible that 20-HETE contributes to additional calcium entry in response to extracellular ATP. In this regard, Zhao et al. (35) showed that the intracellular increase in calcium concentration seen in vascular smooth muscle cells in response to ATP could be partially attenuated by the 20-HETE antagonist 20-HEDE.
Early experiments by Azar et al. (3) showed that Dahl SS rats have a decreased Af-Art resistance, leading to an increased Our results differ somewhat from those of Frisbee et al. (10) . Unlike our results with the Af-Art, they did not find an impairment of the myogenic response in skeletal muscle arteries. Since the myogenic response mechanisms are tissuespecific (9), this is likely due to differences between the vascular beds.
It has been described that even when fed normal-salt diets, older Dahl SS rats have a higher than normal BP, which could potentially affect our results. However, because of technical limitations on dissection of older animals, we limited our study to rats in the 80-to 100-g range. Using these animals, we found no difference between Dahl SS and Dahl SR in BP, as measured by tail cuff (range 90 -120 mmHg).
In addition to the Dahl SS rat, other rat strains with impaired myogenic response, such as the Fawn-Hooded rat, present severe renal damage (30). Churchill et al. (8) showed that kidneys from the Brown Norway (BN) rat, a normotensive strain with impaired myogenic response, are very sensitive to renal damage when exposed to increased BP levels. On the other hand, as we previously showed, SHR have enhanced myogenic response (25) , which may act to preserve renal function in the face of increased systolic BP (22) . In fact, SHR can be rendered susceptible to renal damage by either unilateral nephrectomy (24) , or congenic transfer of chromosome 1 from the BN rat (SHR.BN1-D1Mit3/Igf2) (28), i.e., two approaches expected to impair the myogenic response (4, 8) . Thus, an impaired myogenic response appears to be a permissive factor for hypertensive glomerulosclerosis to develop.
Studies of whole kidney autoregulation demonstrate a link between reduced autoregulatory capacity and hypertensive injury (22) . However, the specific contributions of impairments in myogenic vs. nephron mechanisms [such as TGF and CTGF] are not fully known, due to inherent difficulties of whole kidney models to assess the individual contributions of these interacting systems. Our experiments in isolated Af-Arts directly point to an impairment in Dahl SS myogenic response. Nevertheless, our studies do not exclude a role of nonmyogenic (nephron) mechanisms contributing to an impaired Af-Art autoregulation in the Dahl SS rats. Indeed, we recently showed that Dahl SS have lower TGF and greater CTGF than Dahl SR and that CTGF antagonizes TGF (31) . Taken together, these findings may explain the increase in vasodilatation, glomerular capillary pressure, and glomerular damage in SS hypertension. Put in perspective, our studies suggest that strategies that increase 20-HETE could be used to restore the myogenic response. For example, since peroxisome proliferator-activated receptor ␣ (PPAR␣) is known to be expressed in the Af-Art (15) , and its activation induces CYP4A expression and 20-HETE production, it is possible that PPAR␣ agonists such as the fibric acid derivatives clofibrate and fenofibrate, commonly used in humans as hypolipidemic drugs, could be used in the future to restore the myogenic response in patients with saltsensitive hypertension.
DISCLOSURES
No conflicts of interest, financial or otherwise, are declared by the author(s). 
AUTHOR CONTRIBUTIONS
